Image Credit: serezniy/123rf.com
Australia is on track to become the first country to eliminate cervical cancer, a goal it aims to achieve by 2035 through a robust combination of HPV vaccination and an enhanced screening system. This groundbreaking initiative has garnered international attention as a model for public health.
The journey began in 2006 when researchers at the University of Queensland developed Gardasil, a vaccine targeting HPV, the primary cause of cervical cancer. Australia launched its national vaccination program in 2007, becoming the first country to do so. Initially aimed at girls, the program was expanded in 2013 to include boys, recognizing their role in the transmission of HPV.
Significant advancements in screening methods followed, with Australia adopting an HPV-based cervical screening test in 2017 that requires testing only every five years. Additionally, the option for self-sampling was introduced, facilitating access for women who may face barriers to traditional pelvic exams.
These efforts have resulted in a dramatic decline in cervical cancer rates. Since 1982, both incidence and mortality rates have halved. Notably, data from 2021 indicated no cervical cancer cases diagnosed in women under the age of 25 for the first time, underscoring the success of the vaccination initiative.
Currently, Australia reports approximately 6.3 new cases of cervical cancer per 100,000 women, still above the World Health Organization’s elimination threshold of fewer than four cases per 100,000. Vaccination rates among girls under 15 exceed 80 percent, and 85 percent of women in the critical screening age group have undergone testing.
However, disparities persist, particularly among Aboriginal and Torres Strait Islander women, who face cervical cancer rates twice the national average. Factors contributing to this gap include vaccine hesitancy, rising healthcare costs, and missed school-based vaccinations. Projections suggest it may take an additional 12 years for Indigenous women to reach the elimination target.
Australia’s approach has set a global precedent, influencing countries like Sweden and Rwanda, which aim to eliminate cervical cancer by 2027. However, funding challenges, particularly in lower-income countries, pose significant obstacles. As Australia extends its support to neighboring nations like Vanuatu and Papua New Guinea, the future of this public health initiative remains closely watched amid a broader decline in global health investment. The strides made in Australia signal a pivotal shift in the fight against cervical cancer, offering hope for millions affected by the disease worldwide.
Check out the original article here: Source link
